{"DataElement":{"publicId":"3253084","version":"1","preferredName":"Patient N Stage Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status relating N stage (N refers to the extent of lymph node involvement) as a determination whether a patient/participant is suitable for enrollment in a study according to protocol criteria and procedures.","longName":"3253081v1.0:3253082v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3253081","version":"1","preferredName":"Patient N Stage Clinical Trial Eligibility Criteria","preferredDefinition":"information relating N stage (N refers to the extent of lymph node involvement) as a determination whether a patient/participant is suitable for enrollment in a study according to protocol criteria and procedures.","longName":"2233604v1.0:3253079v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3253079","version":"1","preferredName":"N Stage Clinical Trial Eligibility Criteria","preferredDefinition":"One criteria of the TMN staging system. N refers to the extent of lymph node involvement.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25580:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F969D1-7BC5-11AC-E040-BB89AD4360D5","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"ONEDATA","dateModified":"2011-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F969D1-7BD6-11AC-E040-BB89AD4360D5","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3253082","version":"1","preferredName":"N Stage Clinical Trial Eligibility Criteria Status","preferredDefinition":"the status of a patient's N stage in relation to clinical trial eligibility.","longName":"3253082v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0-1","valueDescription":"N0-1","ValueMeaning":{"publicId":"3687401","version":"1","preferredName":"N0-1","longName":"3687401","preferredDefinition":"N0-1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5CA35AA-9F0D-FFA5-E040-BB89AD435F4C","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"PATELV","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5CA35AA-9F26-FFA5-E040-BB89AD435F4C","beginDate":"2013-02-15","endDate":null,"createdBy":"PATELV","dateCreated":"2013-02-15","modifiedBy":"ONEDATA","dateModified":"2013-02-15","deletedIndicator":"No"},{"value":"N2","valueDescription":"N2","ValueMeaning":{"publicId":"2568788","version":"1","preferredName":"N2","longName":"2568788","preferredDefinition":"N2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D5CA35AA-9F30-FFA5-E040-BB89AD435F4C","beginDate":"2013-02-15","endDate":null,"createdBy":"PATELV","dateCreated":"2013-02-15","modifiedBy":"ONEDATA","dateModified":"2013-02-15","deletedIndicator":"No"},{"value":"N1-3","valueDescription":"N1-3","ValueMeaning":{"publicId":"3253083","version":"1","preferredName":"N1-3","longName":"3253083","preferredDefinition":"N1-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F969D1-7BFE-11AC-E040-BB89AD4360D5","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7F969D1-7C17-11AC-E040-BB89AD4360D5","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"ONEDATA","dateModified":"2011-07-13","deletedIndicator":"No"},{"value":"N0","valueDescription":"N0","ValueMeaning":{"publicId":"2568786","version":"1","preferredName":"N0","longName":"2568786","preferredDefinition":"N0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9BF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7F969D1-7C21-11AC-E040-BB89AD4360D5","beginDate":"2009-01-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"ONEDATA","dateModified":"2011-07-13","deletedIndicator":"No"},{"value":"N2-3","valueDescription":"N2 Stage Finding N3 Stage Finding","ValueMeaning":{"publicId":"3812310","version":"1","preferredName":"N2 Stage Finding N3 Stage Finding","longName":"3812310","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.: A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2 TNM Finding","conceptCode":"C48786","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E1A2BE14-DB80-00DD-E040-BB89AD432252","latestVersionIndicator":"Yes","beginDate":"2013-07-16","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-07-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E1A2BE14-DB99-00DD-E040-BB89AD432252","beginDate":"2013-07-16","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-07-16","modifiedBy":"ONEDATA","dateModified":"2013-07-16","deletedIndicator":"No"},{"value":"N1","valueDescription":"N1 Stage Finding","ValueMeaning":{"publicId":"3906574","version":"1","preferredName":"N1 Stage Finding","longName":"3906574","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E723165B-9D68-76D4-E040-BB89AD436665","latestVersionIndicator":"Yes","beginDate":"2013-09-24","endDate":null,"createdBy":"PATELV","dateCreated":"2013-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E723165B-9D80-76D4-E040-BB89AD436665","beginDate":"2013-09-24","endDate":null,"createdBy":"PATELV","dateCreated":"2013-09-24","modifiedBy":"ONEDATA","dateModified":"2013-09-24","deletedIndicator":"No"},{"value":"N0-2a","valueDescription":"N0 Stage Finding N1 Stage Finding N2a Stage Finding","ValueMeaning":{"publicId":"3918190","version":"1","preferredName":"N0 Stage Finding N1 Stage Finding N2a Stage Finding","longName":"3918190","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.: A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4-6 regional lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N2a TNM Finding","conceptCode":"C48711","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2a TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm); for cutaneous melanoma it refers to micrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4-6 regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E864E742-27F8-2BB0-E040-BB89AD430F2C","latestVersionIndicator":"Yes","beginDate":"2013-10-10","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E864E742-2811-2BB0-E040-BB89AD430F2C","beginDate":"2013-10-10","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-10","modifiedBy":"ONEDATA","dateModified":"2013-10-10","deletedIndicator":"No"},{"value":"N2b-3","valueDescription":"N2b Stage Finding N3 Stage Finding","ValueMeaning":{"publicId":"3918191","version":"1","preferredName":"N2b Stage Finding N3 Stage Finding","longName":"3918191","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases; for cutaneous melanoma it refers to macrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in seven or more regional lymph nodes.: A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2b TNM Finding","conceptCode":"C48712","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes.  The definition of N2b TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases only in clinically detected ipsilateral internal mammary nodes and in the absence of clinically evident level I, II axillary lymph node metastases; for cutaneous melanoma it refers to macrometastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in seven or more regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E864E742-281E-2BB0-E040-BB89AD430F2C","latestVersionIndicator":"Yes","beginDate":"2013-10-10","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E864E742-2837-2BB0-E040-BB89AD430F2C","beginDate":"2013-10-10","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-10","modifiedBy":"ONEDATA","dateModified":"2013-10-10","deletedIndicator":"No"},{"value":"N+","valueDescription":null,"ValueMeaning":{"publicId":"13262175","version":"1","preferredName":"N+","longName":"13262175v1.00","preferredDefinition":"N+","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7FC488D-1317-5B37-E053-731AD00A8E61","latestVersionIndicator":"Yes","beginDate":"2023-03-28","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-28","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7FC488D-131A-5B37-E053-731AD00A8E61","beginDate":"2023-03-28","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-28","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","deletedIndicator":"No"},{"value":"N0/Nx with<10 nodes removed","valueDescription":null,"ValueMeaning":{"publicId":"13262176","version":"1","preferredName":"N0/Nx with<10 nodes removed","longName":"13262176v1.00","preferredDefinition":"N0/Nx with<10 nodes removed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7FC488D-1318-5B37-E053-731AD00A8E61","latestVersionIndicator":"Yes","beginDate":"2023-03-28","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-28","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7FC488D-131B-5B37-E053-731AD00A8E61","beginDate":"2023-03-28","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-28","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","deletedIndicator":"No"},{"value":"N0 with >= 10 nodes removed","valueDescription":null,"ValueMeaning":{"publicId":"13262177","version":"1","preferredName":"N0 with >= 10 nodes removed","longName":"13262177v1.00","preferredDefinition":"N0 with >= 10 nodes removed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7FC488D-1319-5B37-E053-731AD00A8E61","latestVersionIndicator":"Yes","beginDate":"2023-03-28","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-28","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7FC488D-131C-5B37-E053-731AD00A8E61","beginDate":"2023-03-28","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-28","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F969D1-7BE8-11AC-E040-BB89AD4360D5","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":"3/28/2023: Added PVs per CADSR0002213.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4171053","version":"1","longName":"RTOG-1008","context":"NRG"}]}],"AlternateNames":[{"name":"PT_N_STG_CLIN","type":"Context Short Name","context":"CTEP"},{"name":"3253081v1.0:3253082v1.0","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Nodal status","type":"Preferred Question Text","description":"Nodal status","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Specify N stage","url":null,"context":"CTEP"},{"name":"Alliance text 1","type":"Alternate Question Text","description":"Pathological nodal status","url":null,"context":"Alliance"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F969D1-7C2B-11AC-E040-BB89AD4360D5","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"ZHWENDY","dateModified":"2023-03-28","changeDescription":null,"administrativeNotes":"3/28/2023: Added AQT per CADSR0002213.wz","unresolvedIssues":null,"deletedIndicator":"No"}}